Digna Biotech, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Digna Biotech, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					              Digna Biotech, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances
                                              Profile
       Reference Code: GDPH104710D                                                                                                           Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Digna Biotech, S.L. (Digna) is a biotechnology company. It focuses on the
                                                                                                              Digna Biotech, S.L., Pharmaceuticals & Healthcare,
      development and commercialization of pharmaceutical products discovered by the
                                                                                                              Key Facts
      Centro De Investigacion Medica Aplicada (CIMA) in Pamplona. Digna's products
      portfolio includes 12 therapeutic candidates, four clinical-stage products, four                         Web Address                      www.dignabiotech.com
      diagnostic tests and two research products. These therapeutic drugs and
                                                                                                               Revenue (US$ million)                           NA
      diagonostic tests are indicated for treatment in therapeutic areas such as, oncology,
      liver diseases, dermatology, cardiovascular, autoimmune diseases and                                     Number of Employees                                     30
      ophthalmology. The company established various collaborations with Proyecto de                           GlobalData
      Biomedicina CIMA, S.L.

      Financial Deals Landscape
        Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals by                       Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                 2                  2           2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                          1


                                                                                                                          0              0               0         0
                                                                                                          0
                                                                                                               2007      2008   2009    2010   2011     2012    YTD
                                                                                                                                                                2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals                         Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013

                         8
                               6
          No. of Deals




                                                                                                          3
                                                                                           No. of Deals




                         6                                                                                           3          3        3          3
                                                                                                                                                               2
                         4                                                                                2
                         2              1
                                                 0         0         0                                    1
                         0
                             Europe   North     Asia-    Middle   South
                                      Americ   Pacific    East     and                                    0
                                        a                 and     Central                                       Central Gastroi Infectio Oncolo              Immun
                                                         Africa   Americ                                        Nervou ntestin     us      gy                 ology
                                                                    a                                             s       al    Disease
                                                                                                                System


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




Digna Biotech, S.L. - Pharmaceuticals & Healthcare - Deals and                                                                                 Reference Code: GDPH104710D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................... 3
       Digna Biotech, S.L., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................... 5
       Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................... 6
       Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ..................................................... 7
       Digna Biotech, S.L., Medical Devices Deals, 2007 to YTD 2013........................................................................................................ 8
       Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................................................ 9
       Digna Biotech, S.L., Pharmaceuticals & Healthcare, Deal Details ................................................................................................... 10
          Venture Financing......................................................................................................................................................................... 10
             Hepacyl Therapeutics Secures $3.1 Million In Venture Financing ............................................................................................ 10
             Digna Biotech Secures Venture Financing ................................................................................................................................ 11
          Partnerships.................................................................................................................................................................................. 12
             Flamel Technologies Enters Into Co-Development Agreement With Digna Biotech ................................................................. 12
             IDIBAPS, CIMA And Digna Biotech Enter Into Agreement With OWL Genomics ..................................................................... 14
             Digna Biotech Enters Into Agreement With Aachen Resonance To Develop Drug Eluting Devices ......................................... 16
          Licensing Agreements .................................................................................................................................................................. 17
             Biotecnol And Digna Biotech Enter Into Licensing Agreement With Genentech ....................................................................... 17
             Amsterdam Molecular Therapeutics Enters Into An Agreement With Digna Biotech ................................................................ 19
       Digna Biotech, S.L. - Key Competitors ............................................................................................................................................. 20
       Key Employees ................................................................................................................................................................................ 21
       Locations And Subsidiaries .............................................................................................................................................................. 22
          Head Office ................................................................................................................................................................................... 22
          Other Locations & Subsidiaries ..................................................................................................................................................... 22
       Appendix .......................................................................................................................................................................................... 23
          Methodology .................................................................................................................................................................................
				
DOCUMENT INFO
Description: Digna Biotech, S.L. (Digna) is a biotechnology company. It focuses on the development and commercialization of pharmaceutical products discovered by the Centro De Investigacion Medica Aplicada (CIMA) in Pamplona. Digna's products portfolio includes 12 therapeutic candidates, four clinical-stage products, four diagnostic tests and two research products. These therapeutic drugs and diagonostic tests are indicated for treatment in therapeutic areas such as, oncology, liver diseases, dermatology, cardiovascular, autoimmune diseases and ophthalmology. The company established various collaborations with Proyecto de Biomedicina CIMA, S.L. (BITA), Centro De Investigacion En Farmacobiologia Aplicada (CIFA), CIMA, Sociedad de Desarrollo de Navarra (SODENA), University of Navarra and University Clinic of Navarra for the use of research facilities and development of its pipeline products. The company also operates a US-based subsidiary, namely, DIGNA Biotech L.L.C. Digna is headquartered in Pamplona, Spain.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.